eFFECTOR Therapeutics Inc

+0.02 (+4.71%)
: $0.49 -0.02 (-4.50%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)21.21M
Current PE3.76
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$1.11 Million
Adjusted EPS-$0.27
See more estimates
10-Day MA$0.49
50-Day MA$0.45
200-Day MA$1.03
See more pivots

eFFECTOR Therapeutics Inc Stock, NASDAQ:EFTR

142 North Cedros Avenue, Suite B, Solana Beach, California 92075
United States of America
Phone: +1.858.925.8215
Number of Employees: 13


eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of a new class oncology drugs known as selective translation regulator inhibitors (STRIs). Its STRI product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase 1/2 (MNK 1/2). The company was founded by Kevan Shokat, Davide Ruggero, and Siegfried Reich on May 1, 2012 and is headquartered in Solana Beach, CA.